IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 54.14

Change

-0.41 (-0.75)%

Market Cap

N/A

Volume

0.09M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-15 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-0.85 (-0.61%)

USD 37.98B
FHLC Fidelity® MSCI Health Care In..

-0.38 (-0.59%)

USD 2.70B
FXH First Trust Health Care AlphaD..

-1.04 (-1.06%)

USD 0.89B
XHE SPDR® S&P Health Care Equipme..

-1.04 (-1.36%)

USD 0.18B
IDNA iShares Genomics Immunology an..

-0.08 (-0.41%)

USD 0.10B
SBIO ALPS Medical Breakthroughs ETF

+0.21 (+0.79%)

USD 0.09B
XHS SPDR® S&P Health Care Service..

-0.69 (-0.71%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.19 (-0.73%)

USD 0.04B
BBP Virtus LifeSci Biotech Product..

+0.06 (+0.12%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.08 (+0.49%)

USD 0.01B

ETFs Containing IHF

MSSS Northern Lights Fund Trus.. 10.15 % 0.00 %

-0.01 (-0.03%)

USD 0.10B
LCR Managed Portfolio Series 1.91 % 0.00 %

+0.09 (+-0.03%)

USD 0.07B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.82% 100% F 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.82% 100% F 94% A
Trailing 12 Months  
Capital Gain 6.32% 90% A- 70% C-
Dividend Return 0.60% 56% F 9% A-
Total Return 6.92% 90% A- 63% D
Trailing 5 Years  
Capital Gain 43.79% 95% A 54% F
Dividend Return 5.38% 63% D 10% F
Total Return 49.17% 95% A 45% F
Average Annual (5 Year Horizon)  
Capital Gain 3.36% 62% D 48% F
Dividend Return 4.01% 62% D 42% F
Total Return 0.65% 63% D 16% F
Risk Return Profile  
Volatility (Standard Deviation) 19.95% 43% F 52% F
Risk Adjusted Return 20.10% 57% F 38% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.